NCT06360133View on ClinicalTrials.gov

Study of 5% VVN001 Ophthalmic Solution in Dry Eye Disease

PHASE3RecruitingINTERVENTIONAL

Enrollment

700

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions

Dry Eye

Interventions

DRUG

VVN001 Ophthalmic Solution, 5%

VVN001 Ophthalmic Solution, 5%

DRUG

VVN001 Ophthalmic Solution, Vehicle

VVN001 Ophthalmic Solution, Vehicle

Trial Locations (1)

Unknown

RECRUITING

Eye & Ent Hospital of Fudan University, Shanghai

All Listed Sponsors

lead

VivaVision Biotech, Inc

INDUSTRY